Aduro Biotech Company Profile (NASDAQ:ADRO)

About Aduro Biotech

Aduro Biotech logoAduro Biotech, Inc. is a clinical-stage immunotherapy company. The Company is focused on the discovery, development and commercialization of therapies that transform the treatment of various diseases. The Company has developed approximately three technology platforms, which include Live, Attenuated, Double-Deleted (LADD), Stimulator of Interferon Genes (STING) Pathway Activator and B-select monoclonal antibodies. Its LADD product candidates include CRS-207, ADU-623, ADU-741 and ADU-214. Its STING Activator product candidates include ADU-S100. Its LADD technology platform is engineered to express tumor-associated antigens to induce specific and targeted immune responses. Its STING Pathway Activator platform is designed to activate the intracellular STING receptor, resulting in a tumor-specific immune response. Its B-select monoclonal antibody platform includes various immune modulating assets in research and preclinical development.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADRO
  • CUSIP:
Key Metrics:
  • Previous Close: $13.95
  • 50 Day Moving Average: $14.47
  • 200 Day Moving Average: $13.22
  • 52-Week Range: $7.26 - $34.95
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.70
  • P/E Growth: 0.22
  • Market Cap: $908.50M
  • Outstanding Shares: 64,754,000
  • Beta: 3.86
Additional Links:
Companies Related to Aduro Biotech:

Analyst Ratings

Consensus Ratings for Aduro Biotech (NASDAQ:ADRO) (?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $22.00 (56.14% upside)

Analysts' Ratings History for Aduro Biotech (NASDAQ:ADRO)
DateFirmActionRatingPrice TargetDetails
8/5/2016Canaccord GenuityReiterated RatingBuy$30.00View Rating Details
7/11/2016Roth CapitalReiterated RatingBuy$22.00View Rating Details
6/6/2016FBR & CoReiterated RatingBuyView Rating Details
5/17/2016Leerink SwannReiterated RatingOutperform$48.00 -> $14.00View Rating Details
3/15/2016Bank of America Corp.DowngradeBuy -> Underperform$32.00 -> $14.00View Rating Details
2/2/2016William BlairInitiated CoverageBuyView Rating Details
12/1/2015Oppenheimer Holdings Inc.DowngradeOutperform -> Market PerformView Rating Details
(Data available from 8/31/2014 forward)


Earnings History for Aduro Biotech (NASDAQ:ADRO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2016($0.18)$0.03$25.24 million$39.00 millionViewN/AView Earnings Details
5/2/2016Q116($0.25)($0.45)ViewN/AView Earnings Details
3/8/2016Q415($0.15)$0.04$34.38 millionViewN/AView Earnings Details
11/24/2015Q3($0.08)$0.01$15.80 million$19.15 millionViewN/AView Earnings Details
8/10/2015Q215($0.01)($0.50)$1.00 million$9.90 millionViewN/AView Earnings Details
5/28/2015Q115($0.03)($39.97)$9.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Aduro Biotech (NASDAQ:ADRO)
Current Year EPS Consensus Estimate: $-1.39 EPS
Next Year EPS Consensus Estimate: $-1.62 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20168($0.52)($0.10)($0.29)
Q2 20167($0.46)$0.11($0.18)
Q3 20167($0.52)($0.20)($0.43)
Q4 20167($0.56)($0.21)($0.45)
Q1 20171($0.50)($0.50)($0.50)
Q2 20171($0.50)($0.50)($0.50)
Q3 20171($0.51)($0.51)($0.51)
Q4 20171($0.51)($0.51)($0.51)
(Data provided by Zacks Investment Research)


Dividend History for Aduro Biotech (NASDAQ:ADRO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Aduro Biotech (NASDAQ:ADRO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/11/2016Thomas W DubenskyInsiderSell25,000$15.18$379,500.00View SEC Filing  
7/5/2016Thomas W DubenskyInsiderSell25,000$11.61$290,250.00View SEC Filing  
5/16/2016Thomas W. DubenskyInsiderSell905$8.20$7,421.00View SEC Filing  
1/11/2016Dirk G. BrockstedtVPSell22,000$21.77$478,940.00View SEC Filing  
1/8/2016Gregory W. SchaferCOOSell20,000$23.58$471,600.00View SEC Filing  
1/6/2016Jennifer LewVPSell5,242$25.71$134,771.82View SEC Filing  
1/5/2016Stephen T. IsaacsCEOSell25,000$26.31$657,750.00View SEC Filing  
1/4/2016Thomas W. DubenskyinsiderSell15,000$26.37$395,550.00View SEC Filing  
12/7/2015Gregory W. SchaferCOOSell25,000$29.74$743,500.00View SEC Filing  
12/3/2015Jennifer LewVPSell5,242$29.85$156,473.70View SEC Filing  
12/1/2015Stephen T. IsaacsCEOSell25,000$29.11$727,750.00View SEC Filing  
12/1/2015Thomas W. DubenskyinsiderSell30,000$29.27$878,100.00View SEC Filing  
11/18/2015Jennifer LewVPSell6,712$28.52$191,426.24View SEC Filing  
11/17/2015Gregory W. SchaferCOOSell26,470$28.15$745,130.50View SEC Filing  
11/17/2015Thomas W. DubenskyinsiderSell31,470$28.27$889,656.90View SEC Filing  
11/16/2015Stephen T. IsaacsCEOSell25,000$27.54$688,500.00View SEC Filing  
4/20/2015Jennifer LewVPBuy2,000$17.00$34,000.00View SEC Filing  
4/20/2015Venture (Vi) Inves MorningsideMajor ShareholderBuy441,176$17.00$7,499,992.00View SEC Filing  
4/20/2015William Mariner GreenmanDirectorBuy3,000$17.00$51,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Aduro Biotech (NASDAQ:ADRO)
DateHeadline logoETF’s with exposure to Aduro BioTech, Inc. : August 30, 2016 (NASDAQ:ADRO) - August 30 at 12:18 PM logoAduro BioTech, Inc. breached its 50 day moving average in a Bearish Manner : ADRO-US : August 29, 2016 (NASDAQ:ADRO) - August 29 at 3:45 PM logo1H16 Financial Press Release (NASDAQ:ADRO) - August 29 at 3:45 PM logoAduro BioTech Inc (NASDAQ:ADRO) Gets 1 Recommendations To ... - Investor Newswire (NASDAQ:ADRO) - August 29 at 8:04 AM
News IconBest Biotech Stocks: This $15 Biotech Stock is About to Go Vertical (NASDAQ:ADRO) - August 26 at 11:25 AM logoPTBA Acquires Ignite Resources to Increase Efficiency (NASDAQ:ADRO) - August 26 at 11:25 AM logoChinese July thermal coal imports jump 31% on year to 19-month high (NASDAQ:ADRO) - August 26 at 11:25 AM logoVietnam’s July coal imports surge 141% on year to 1.31 million mt (NASDAQ:ADRO) - August 23 at 9:33 AM logoMetallurgical coal poised for biggest weekly price surge since 2011 Queensland floods (NASDAQ:ADRO) - August 23 at 9:33 AM logoWill Aduro BioTech Inc (NASDAQ:ADRO) Hit $22 Price Target? - Investor Newswire (NASDAQ:ADRO) - August 22 at 8:06 AM
News IconHow is the Crowd Rating Shares of Aduro BioTech Inc (NASDAQ:ADRO)? - Post News (NASDAQ:ADRO) - August 19 at 3:34 PM logoU.S. coal use may rise, but unlikely to unseat natgas as power king (NASDAQ:ADRO) - August 19 at 11:33 AM logoChina’s Coal-Market Reforms Fuel Rebound in Prices (NASDAQ:ADRO) - August 19 at 11:33 AM logoAnalysts See Sales Of $144.695 For Aduro BioTech Inc (NASDAQ:ADRO) - Investor Newswire (NASDAQ:ADRO) - August 17 at 8:50 PM logoChina steel, coal companies jump on debt-to-equity swap proposals (NASDAQ:ADRO) - August 16 at 11:55 AM logoWill Aduro BioTech Inc (NASDAQ:ADRO) Surprise Analysts This Quarter? (NASDAQ:ADRO) - August 15 at 8:51 PM logoWill Aduro BioTech Inc (NASDAQ:ADRO) Surprise Analysts This Quarter? - Stocks Daily (NASDAQ:ADRO) - August 15 at 3:21 PM logoAduro Biotech, Inc. (ADRO) Holdings Decreased by Fmr LLC - Finance Daily (NASDAQ:ADRO) - August 12 at 3:19 PM logoADURO BIOTECH, INC. Financials (NASDAQ:ADRO) - August 11 at 3:19 PM logoETF’s with exposure to Aduro BioTech, Inc. : August 11, 2016 (NASDAQ:ADRO) - August 11 at 12:30 PM logoAduro BioTech Inc (NASDAQ:ADRO) Records An Estimated Annual Sales Mean Of $144.695 - Investor Newswire (NASDAQ:ADRO) - August 10 at 9:44 PM logoBig Movers: Aduro BioTech, Inc. (NASDAQ:ADRO), Annaly Capital Management, Inc. (NYSE:NLY), Sprint Corporation ... - KC Register (NASDAQ:ADRO) - August 10 at 12:12 PM logoAduro BioTech, Inc. :ADRO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:ADRO) - August 9 at 3:35 PM logoIndonesian Adaro Energy’s H1 2016 coal production stable on year (NASDAQ:ADRO) - August 8 at 3:19 PM logoCommittee suggests new coal price formula for power plants (NASDAQ:ADRO) - August 8 at 3:19 PM logoAdaro Energy on full offensive for Indonesia’s power sector (NASDAQ:ADRO) - August 8 at 3:19 PM logoITM readies $300m for acquisitions, capex (NASDAQ:ADRO) - August 8 at 3:19 PM logoChina Taps Coal Giants as Asset Managers to Guide Supply Cuts (NASDAQ:ADRO) - August 5 at 11:42 AM logoThermal coal — early signs of recovery? (NASDAQ:ADRO) - August 5 at 11:42 AM logoAnglo American appoints new CEOs for coal and iron ore businesses (NASDAQ:ADRO) - August 5 at 11:42 AM logoAduro Biotech to Present at Canaccord Genuity Growth Conference (NASDAQ:ADRO) - August 4 at 11:50 AM logoAduro Biotech Reports Second Quarter 2016 Financial Results (NASDAQ:ADRO) - August 3 at 8:57 PM logoAduro Biotech tops Street 2Q forecasts (NASDAQ:ADRO) - August 3 at 8:56 PM logoExpected For Aduro BioTech Inc (NASDAQ:ADRO) Sales Of $139.845 - Investor Newswire (NASDAQ:ADRO) - July 29 at 12:17 PM logo2016 Annual Public Expose Material (NASDAQ:ADRO) - July 28 at 11:08 AM
News IconStock Up Nicely This Week: Aduro BioTech, Inc. (NASDAQ:ADRO) - TGP (NASDAQ:ADRO) - July 23 at 3:18 PM logoWeather-related disruption could further boost thermal coal prices: analysts (NASDAQ:ADRO) - July 22 at 8:38 AM logoChina’s June coal output falls 17% on year to 277.54 million mt (NASDAQ:ADRO) - July 22 at 8:38 AM logoDomestic coal consumption cushions low global demand (NASDAQ:ADRO) - July 22 at 8:38 AM
News IconAduro BioTech Inc Has Another Very Strong Trading Session - Consumer Eagle (NASDAQ:ADRO) - July 20 at 10:08 PM logoAduro BioTech Inc (NASDAQ:ADRO) Expected To Post Sales Of $139.845 - Investor Newswire (NASDAQ:ADRO) - July 20 at 10:08 PM
News IconShares Losing Ground in Session: Aduro BioTech, Inc. (NASDAQ:ADRO) - TGP (NASDAQ:ADRO) - July 19 at 3:19 PM logoToday's Watch List: Galapagos NV (NASDAQ:GLPG), Aduro BioTech, Inc. (NASDAQ:ADRO), Apogee Enterprises, Inc ... - KC Register (NASDAQ:ADRO) - July 18 at 3:18 PM logoChina reaffirms plan to cut steel and coal production (NASDAQ:ADRO) - July 18 at 5:38 AM logoStrong Sell Calls For Aduro BioTech Inc (NASDAQ:ADRO) At 0 - Investor Newswire (NASDAQ:ADRO) - July 17 at 3:17 PM
News IconCrowd Rating and Earnings Recap for Aduro BioTech Inc (NASDAQ:ADRO) - Telanagana Press (NASDAQ:ADRO) - July 16 at 3:18 PM
News IconAduro Biotech Incorporated (NASDAQ:ADRO) Short Interest Increased By 14.17% - Press Telegraph (NASDAQ:ADRO) - July 16 at 3:18 PM logoChina to cut coal mining capacity of SASAC-owned companies by 10% in 2 years (NASDAQ:ADRO) - July 15 at 11:28 AM
News IconAduro BioTech Inc (NASDAQ:ADRO) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:ADRO) - July 14 at 3:19 PM logoAduro BioTech Inc Realized Volatility Hits Extreme Level - CML News (NASDAQ:ADRO) - July 14 at 3:19 PM


Aduro Biotech (NASDAQ:ADRO) Chart for Wednesday, August, 31, 2016

Last Updated on 8/31/2016 by Staff